Guardant Health director proposes $17.3K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Guardant Health, Inc. director Tariq Musa reported a proposed sale of 116 common shares, with an aggregate market value of $17,349, at an approximate sale date of November 16, 2026. The notice names Charles Schwab & Co., Inc. as broker. The shares were acquired on September 15, 2026, through a restricted stock lapse as equity compensation. Musa also reported three earlier sales of 116 shares each, dated August 17, September 16 and October 16, 2026, with gross proceeds of $18,148, $20,300 and $19,242, respectively. The notice gives December 17, 2025, as the plan-adoption or instruction date if relying on Rule 10b5-1.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Restricted Stock Lapse financial
Equity Compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior Guardant Health (GH) stock sales did Tariq Musa report?
What Rule 10b5-1 date is listed for Tariq Musa's proposed GH sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.